Cargando…
Anti-band 3 and anti-spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia
Clearance of non-infected red blood cells (nRBCs) is one of the main components of anemia associated with Plasmodium vivax malaria. Recently, we have shown that anemic patients with P. vivax infection had elevated levels of anti-RBCs antibodies, which could enhance in vitro phagocytosis of nRBCs and...
Autores principales: | Mourão, Luiza Carvalho, Baptista, Rodrigo de Paula, de Almeida, Zélia Barbosa, Grynberg, Priscila, Pucci, Maíra Mazzoni, Castro-Gomes, Thiago, Fontes, Cor Jesus Fernandes, Rathore, Sumit, Sharma, Yagya D., da Silva-Pereira, Rosiane A., Bemquerer, Marcelo Porto, Braga, Érika Martins |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993813/ https://www.ncbi.nlm.nih.gov/pubmed/29884876 http://dx.doi.org/10.1038/s41598-018-27109-6 |
Ejemplares similares
-
An immunoproteomic approach reveals a different pattern of non-infected erythrocyte membrane protein recognition by antibodies from non-anemic and anemic patients with patent Plasmodium vivax infection
por: Mourao, Luiza, et al.
Publicado: (2014) -
Anti-erythrocyte antibodies may contribute to anaemia in Plasmodium vivax malaria by decreasing red blood cell deformability and increasing erythrophagocytosis
por: Mourão, Luiza Carvalho, et al.
Publicado: (2016) -
Polymorphism at the apical membrane antigen 1 locus reflects the world population history of Plasmodium vivax
por: Grynberg, Priscila, et al.
Publicado: (2008) -
Preliminary assessment of anti-α-Gal IgG and IgM levels in patients
with patent Plasmodium vivax infection
por: Coelho, Zélia Barbosa de Almeida, et al.
Publicado: (2019) -
Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection
por: Sepúlveda, Nuno, et al.
Publicado: (2016)